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THE RELATIONSHIP BETWEEN PERCEIVED STRESS AND SMOKING: 
FOCUSING ON SCHIZOPHRENIA AND COMPARATIVE SUB-GROUPS 
DIAGNOSED WITH MENTAL ILLNESS 
WANDA K. SAVIOLI 
ABSTRACT 
      The context for this research project is a population of individuals diagnosed with 
a mental illness; schizophrenia, bipolar disorder, depressive disorders, or other diagnosis 
as specified by participant.  Research has shown that 87% of individuals diagnosed with 
schizophrenia are smokers and 65-75% of those diagnosed with bipolar or depressive 
disorders smoke compared to 20% from the general population.  The purpose of this 
study is to determine if perceived stress is positively associated with cigarette dependence 
among a study sample of non-psychiatric participants and those diagnosed with a mental 
illness.  A correlational survey based design was used to test five hypotheses of perceived 
stress and smoking.  Survey data was obtained from smokers and non-smokers 
hospitalized at Windsor-Laurelwood Center for Behavioral Medicine.  Included in this 
study sample were smokers and non-smokers from Cleveland State University 
representative of the general population.  The survey instruments used in this data 
collection included the psychometric assessments; Perceived Stress Scale, Cigarette 
Dependence Scale, and the Reasons for Quitting Scale.   
 Consistent with prior research and published government data on smoking rates 
for those diagnosed with a mental illness, this sampling of participants reported similar 
smoking rates at 88% for those with schizophrenia, and 75% and 74% for those 
diagnosed with bipolar and depressive disorders respectively. The first hypothesis was 
 vi 
supported in this research; the levels of perceived stress are significantly greater in those 
with mental illness compared to the group drawn from the general population.  A second 
hypothesis was supported; perceived stress is positively related to cigarette dependence.  
Though, this relationship between perceived stress and cigarette dependence was not 
shown to be greater in those with schizophrenia, nor was it stronger than those with 
bipolar or depressive disorders.   
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CHAPTER I 
                                             INTRODUCTION 
 Over the past four decades the United States has experienced an impressive 
reduction in smoking rates among all age groups.  According to the Center for Disease 
Control and Prevention, the current smoking rate has dropped to less than 20% (19.8%) 
in the general U.S. population (Center for Disease and Prevention [CDC], 2008), and the 
World Health Organization supports smoking cessation as the only intervention to reduce 
tobacco related morbidity and mortality (World Health Organization [WHO], 2003).  Yet, 
those diagnosed with a severe mental illness (SMI); schizophrenia, bipolar, or depressive 
disorders are far less fortunate.  They tend not only to have higher nicotine dependence 
and addiction to smoking, but lower smoking cessation rates than the general population.  
The culmination of higher co-morbid incidence and the medical consequences from 
tobacco-related diseases raises the risk profile and decreases the quality of life for anyone 
diagnosed with a severe mental illness.  Hence, those inflicted with a mental illness merit 
special attention, and the CDC has campaigned to identify and disseminate an evidence 
based need to reduce tobacco-related disparities.   
The CDC reports 60-70% of those diagnosed with bipolar or depressive disorders 
continue to smoke, and an alarming 90% of those diagnosed with schizophrenia are 
current smokers (“Schizophrenia and Cigarette Smoking”, 2006; WHO, n.d.).  The 
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National Institute of Mental Health reports approximately 6% of the U.S. population meet 
the criteria for SMI (National Institute of Mental Health,[NIMH], 2008) with varying 
degrees of all diagnosable mental illnesses range upwards of 12%-26% of the U.S. 
population (Leonard et al., 2001; NIMH, 2008).  Though, those with mental illness 
account for nearly half of all cigarette consumption in the United States (Lasser et al., 
2000; NIMH, 2009), with one study reporting this rate of cigarette consumption is closer 
to 70% (Grant, Hasin, Chou, Stinson & Dawson, 2004). 
 According to the National Institute of Mental Health, mental illness is the leading 
cause of disability for Americans between the age of 15-44 (NIMH, 2008), resulting in 
lost earning potential during their most productive adult years.  Based on these studies 
and government reports, those diagnosed with a mental illness contribute exponentially to 
the $167 billion annual cost for smoking-related medical expenses and loss of 
productivity (CDC, 2006).  Furthermore, those with mental illnesses are more likely to 
have more co-morbid medical conditions than the general public.  Also, they are dying 
much younger, with their mortality rate 13-30 years earlier than the general population 
(Colton & Manderscheid, 2006).  Not unlike the general population, heart disease is the 
leading cause of death for this population (Gelenberg, deLeon, Evins, Parks, & Rigotti, 
2008).  However, findings supported by research applying different study design and 
methods have shown that those with schizophrenia are twice as likely to develop 
cardiovascular disease compared to the general population of smokers (Curkendall, Mo, 
Jones, & Glasser, 2001; Leucht, Burkard, Henderson, Maj, & Sartorius, 2007; Goff et al., 
2005). 
 The detrimental effects and financial burden of health related problems associated 
with smoking are not solely restricted to the United States.  Smoking is a global health 
 3 
epidemic, with its hazardous results shared by many countries, societies, and 
communities (Dalack, Healy, & Meadows-Woodruff, 1998; deLeon, 1996; deLeon, 
Beacona, Gurpegui, Gonzalez-Pinto, & Diaz, 2002).  An Australian mental health charity 
reported similar per capita smoking rates as the United States;  with nearly 40% of all 
Australian smokers having a diagnosed mental illness and costing $33 billion a year in 
health related illnesses and lost productivity (SANE, 2007).   
Cigarette smoking is the leading cause of preventable death in the United States, 
resulting in more than 400,000 deaths per year or about one in every five deaths (National 
Institute on Drug Abuse [NIDA], 2008).  The relationships between psychiatric disorders 
and smoking have important implications for public health as well as the financial burden 
to both the individuals and our fragile health care system.  The well-known risk of 
smoking may synergistically exacerbate health risks among this group, making additional 
clinical and research programs essential in addressing this critical public health crisis.   
   Previous research efforts focused on correlational relationships between stress 
and mental illnesses, and cigarette dependence and mental illnesses; however, there is a 
paucity of research testing correlational and causality relationships between stress as the 
independent variable and smoking as the dependent variable in individuals diagnosed 
with schizophrenia, bipolar, and depressive disorders. Extant research has not explored 
the direct effect of perceived stress on smoking.  The literature review section shows that 
a hypothesis linking perceived stress to smoking would be consistent with the larger or 
general finding on smoking among those with mental illnesses.  The intent of this 
research is to examine relationships identifying hypotheses linking one factor, 
perceived stress and the relationship to higher cigarette dependence and decreased 
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motivation to quit for those diagnosed with schizophrenia and comparative sub-
groups of mental illness; bipolar and depressive disorders.   
 
1. The first hypothesis of this study is that the levels of perceived stress 
are significantly greater in the group diagnosed with mental illnesses 
compared with the group drawn from the general population.   
2. The second hypothesis of this study is that perceived stress is positively 
related to cigarette dependence, and this relationship is stronger in 
those diagnosed with schizophrenia.   
3. The third hypothesis is that the relationship between perceived stress 
and cigarette dependence is stronger among those diagnosed with 
schizophrenia than in those diagnosed with bipolar disorder.   
4. The fourth hypothesis is that the relationship between perceived stress 
and cigarette dependence is stronger among those diagnosed with 
schizophrenia than those diagnosed with a depressive disorder.   
5. The fifth hypothesis is that perceived stress is negatively related to 
motivation to quit smoking. This relationship is stronger in those 
diagnosed with a mental illness. 
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CHAPTER II 
LITERATURE REVIEW 
SMOKING and MENTAL ILLNESS 
 Over the past 30 years, Americans have experienced a public outcry calling for 
smoking reform following the nonsmoker’s rights movement and the publicized health 
hazards and risks associated with smoking.  In the 1960s, the U.S. Surgeon General 
began requiring warning labels on cigarette packs, and even though Gallup Poll results 
indicated an increase in public perceptions of smoking risks, there was no immediate 
decline in the U.S. smoking rate.  During the 1970s the smoking rate dropped below 
40%, though it was not until the government initiated proactive regulations in 1989 that 
the smoking rate fell below 30% (Morales, 2008).  This reform encouraged higher state 
and federal tobacco taxes, outlawed smoking in public places and the workplace, banned 
advertising targeted toward children, encouraged avoidance, and ultimately aided 
smokers trying to quit the habit. 
 Regrettably, those with mental illnesses have not reaped the benefits from the 
antismoking campaigns, and over the years have become somewhat resistant to any 
change in smoking behaviors in light of current reforms and social attitudes.  As part of 
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the remaining population of smokers, their co-morbid illness contributes to the ever 
increasing healthcare cost, and it appears this addictive habit is more difficult for them to 
quit compared to the population at large.  They continue to be highly addicted to 
cigarettes (deLeon & Diaz, 2005; George & Vessicchio, 2002), heavier smokers (Dalack, 
Healy, & Meadows-Woodruff, 1998; DeLeon & Diaz, 2005, Hughes, Hatsukami, 
Mitchell, & Dahlgren, 1986; Kelly, & McCreadie, 1999; Lasser et al., 2000), and less 
successful in attempting or maintaining smoking cessation (Addington, el-Guebaly, 
Campbell, Hodgins, & Addington, 1998; Dalack et al., 1998; deLeon, Diaz, Rogers, 
Browne, & Dinsmore, 2002; George, Vessicchio et al., 2000; George & Vessicchio, 
2002; Hughes et al., 1986).  
Over the past 25 years, researchers have continued to focus on co-morbidity 
between physical illness and various mental disorders and on the relationship between 
cigarette smoking and generalized psychiatric disorders while disseminating research 
showing this population continues to smoke at much higher rates than the general 
population (Dalack, & Glassman, 1992; Dickey, Normand, Weiss, Drake, & Azeni, 2002; 
Hughes et al., 1986).  Additionally, the higher the severity of schizophrenic symptoms 
has an impact.  The higher the severity of symptoms, the more likely an individual will 
smoke more frequently and more heavily than lesser degrees of severity (Lohr and Flynn, 
1992).    
Research interests are not only focused on the exploration of the multidimensional 
aspects between medical illnesses and mental illnesses, but also on the behaviors 
associated with smoking.  While many studies have identified areas of interest in 
smoking rates among all mental disorders, recent findings have focused on the 
triangulation between psychological, social, and biological factors, all playing an 
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important role in the high rate of smoking; especially for those diagnosed with 
schizophrenia.   
Research investigation has recently focused on the genetic components associated 
with schizophrenia and nicotine addiction, providing a plausible connection between a 
form of biochemical changes and its affinity with this mental disorder.  Active areas of 
research examining the etiology of schizophrenia and genetic defects link to smoking, 
reporting a gene defect commonality with bipolar disorder (Leonard et al., 2001). 
Even though this defective gene theory does not overtly appear to implicate a 
gene defect relationship with major depression (deLeon, 1996), contradictory research 
suggests genetic factors are likely to predispose and influence the liability to both 
smoking and major depression (Kendler et al., 1993).  Previous researchers have argued 
that studies focusing on one distinct psychiatric disorder provide very little information 
pertaining to these common risk factors for smoking across the entire spectrum of mental 
disorders (Vanable, Carey, Carey, & Maisto; 2003).  More recently researchers have 
noted forms of shared vulnerability or common risk genes linking the full spectrum of 
major psychotic disorders with smoking (Diaz et al., 2009). 
Several recent studies have explored the biological abnormalities of mental 
disorders; including dysregulation and desensitization of the pathophysiological functions 
between nicotinic acetylcholine (Dalack et al., 1998; Leonard, et al., 2000) and the 
mesolimbic dopamine system (George, Verrico, Picciotto, & Roth, 2000).  Prior research 
focused on the nicotine modulation effect on dopamine in the prefrontal region of the 
brain, with dopamine deficiency in this area leading to the negative symptoms of 
schizophrenia, i.e., social apathy and social withdrawal, and excessive dopamine in the 
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mesolimbic area increasing the positive symptoms, i.e., hallucinations and delusions 
(McCloughen, 2003). 
While some researchers have focused on a singular importance of dopamine and 
dopamine receptors, other neurotransmitters and their role in the complex neurocircuity 
in schizophrenia have been identified, including serotonergic, cholinergic, and 
glutamatergic neurotransmitters (George, Zeidonis et al., 2000).  For instance, the 
National Institute of Health (NIH) reports one key neurotransmitter, glutamate, to be 
linked to the genetic deficits spectrum of schizophrenia, suggesting that it contributes to 
the dysfunction of the frontal area of the brain where decision-making and higher order 
thinking occurs. (NIH, 2004).  Stress increases the release of glutamate in the prefrontal 
cortex area and dopamine in the mesolimbic system (Duncan, Sheitman, & Lieberman, 
1999).  
Recent research likely coincides with previous research suggesting those with 
schizophrenia have fewer hippocampal nicotinic receptors, and a failure to activate 
cholinergic inhibitory interneurons, resulting in a decreased gating response to sensory 
stimulation and a sensory overload regulating auditory and cognitive sensory perceptions 
(Freedman, Hall, Adler, & Leonard, 1995).  Other areas of interest include auditory 
sensory gating deficits and the neurochemical changes associated with the alpha 7 
nicotinic cholinergic receptor linked to schizophrenia, with this dysfunctional 
abnormality more specific to the hippocampal alpha 7 nicotine receptor (deLeon, Diaz et 
al., 2002).  With this sensory deficit and the alpha 7 nicotine receptor, nicotine exposure 
during smoking offers temporary improvement and normalization (Leonard et al., 2000; 
Leonard, Mexal, & Freedman, 2007; Olincy et al, 2006).  Nicotine has the ability to 
transiently normalize auditory gating and thus decrease difficulty with processing sensory 
 9 
information (Adler, Hoffer, Wiser, & Freedman, 1993).  Other studies suggest those with 
schizophrenia have an overall reduction in nicotine receptors in the hippocampus, cortex, 
and caudate areas of the brain (Breese et al., 2000).  Prior researchers looked at the 
association between the sensory gate deficit and the defective gene theory, concluding 
this is a matter of a faulty nicotine receptor gene (Brain Disorders, Smoking, & Nicotine 
Addiction, 2006).  Based on data provided by the NIMH Schizophrenia Genetics 
Initiative project, Farone et al. (2004) discovered several nicotinic receptor genes linked 
to smoking traits in schizophrenia.  Saccone et al. (2007) also conducted genotyping 
research showing genetic variants associated with nicotine dependence.  These research 
efforts have shed some light on smoking as a form of self-medication, implicating the 
need for protection from neurotoxicity and enhancement of cognitive processes (Leonard 
et al., 2007). 
Research attention has also been directed to the positive aspect of nicotine on 
cognitive function, including emotion, motivation, attention, behavioral livelihood, and 
alertness due to nicotine interaction with neurotransmitter systems (Adler et al., 1993; 
Dalack et al., 1998; George et al., 2000; Kumari & Postma, 2005).  Nicotine helps with 
the cognitive impairments and overall cognitive processes along with difficulties in 
abstract thinking common in schizophrenia.  For those diagnosed with schizophrenia, 
aspects of smoking and the actions of nicotine may help compensate for some of the 
cognitive impairments associated with the illness and may also counteract the psychotic 
symptoms or alleviate unpleasant side effects common with antipsychotic medications.   
Glynn and Sussman (1990) reported that those with schizophrenia smoke for the 
same reasons as the general population-to settle nerves (52%), out of habit (67%), and for 
relaxation (80%).  For smokers with mental illness, smoking is a central part of life, and 
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considered an affordable luxury.  Research has provided an understanding that smoking 
is a major part of their daily routine, and those with mental illnesses experience less 
satisfaction from other activities in comparison to the pleasure derived from smoking 
(Snyder, McDevitt, & Painter, 2008).  Spring, Pingitore, and McChargue (2003) found 
that persons with schizophrenia are just as aware of the drawbacks and disadvantages of 
smoking as those in the general population, but they perceive more personal benefits 
from smoking versus not smoking. 
Persistent depressive symptoms experienced by some individuals with 
schizophrenia may also influence the prevalence of smoking, suggesting an important 
relationship between depression and nicotine dependence (Breslau, Kilbey, & Andreski, 
1993; Glassman, 1993; Hughes, 1993).  The absence of nicotine increases the risk for 
depression in those predisposed to depressive symptoms (Kotov, Guey, Bromet, & 
Schwartz, 2008; Ziedonis, Kosten, Glazer, & Frances, 1994), making it more difficult to 
contemplate, initiate, or adhere to smoking cessation. 
 Furthermore, studies have shown that those with schizophrenia do not self-
medicate with nicotine to reduce the positive symptoms of schizophrenia; hallucinations, 
delusions, suspiciousness, paranoia or persecution (Lohr & Flynn, 1992; Patkar et al., 
2002), which reflect an excess or distortion of normal functions.  Rather, research 
attention has focused on the aspects of chronic negative symptoms of schizophrenia- 
emotional and social withdrawal, apathy, and lack of energy or motivation, which are 
those that appear to reflect a diminution or loss of normal functions.  These negative 
symptoms are ameliorated with exposure to nicotine while smoking (Dalack et al., 1998; 
Lyon, 1999), with an overall improvement in neuropsychological performance (Lavin, 
Siris, & Mason, 1996).  Individuals diagnosed with schizophrenia are more prone to be 
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smokers and the actual smoking behavior may reduce negative symptoms of the disorder 
(deLeon et al., 1995).  Additionally, nicotine has anxiolytic effects (Diaz et al., 2009), 
with varying degrees of stress reduction, often depending on the degrees of anxiety 
evoked and the response to the event (Morissette, Tull, Gulliver, Kamholz, & Zimering, 
2007).  It is an ongoing dilemma as to why this generalized grouping of mental illnesses 
continue to be so highly addicted to nicotine and less motivated to quit smoking in light 
of social concerns and media attention placed on the health risks associated with 
smoking. 
STRESS and MENTAL ILLNESS 
 There is a clear link between stressors and psychotic episodes (Butzlaff & 
Hooley, 1998; Nuechterlein & Dawson, 1986).  Schizophrenia is a debilitating mental 
disorder, with complexity of the underlying pathophysiology.  Schizophrenia may exist 
alone or in combination with other psychiatric or medical conditions, and is known as a 
biological disease of the brain that ebbs and flows, with acute periods of hallucinations, 
thought confusion, and delusional thinking possibly triggered by a variety of stressors.  It 
usually abates in response to decreased stimuli, calm interactions, and antipsychotic 
medicine (“Understanding and Responding”, n.d.).  Those with schizophrenia have 
altered sensitivity to stress and their environment, in addition to maladaptive coping skills 
during stressful situations (Gispen de Weid, 2000).  
Both social stigmatism (Dixon et al., 2007; Lee, Lee, Chiu, & Kleinman, 2005; 
Rüsch et al., 2009), and negative self perceptions of their mental illness exacerbates their 
stress (Dinos, Stevens, Serfaty, Weich, & King, 2004).  A more recent study by Cooke et 
al. (2007) reported individuals with schizophrenia who have greater awareness and 
insight of their mental illness experience greater distress, as measured by poor self-
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esteem, anxiety, and depression.  Whereas those with poorer insight have developed 
maladaptive coping styles, denial, or have cognitive functioning impairments or deficits.  
However, only slight differences in levels of stress have been reported between the 
diagnostic sub-groups of schizophrenia, bipolar, or depressive disorders (Rüsch et al., 
2009).  When factoring in the added social stigma and self-stigmatization associated with 
their diseases, it is possible that both the nicotine addiction and the smoking behavior 
associated with smoking may help them deal with their stress and anxiety.  Nicotine 
dependence develops when tobacco is used as a coping strategy in response to life 
stressors, and this repeated use as a coping mechanism delays adaptive coping strategies 
and increasing psychological dependence on tobacco (Morissette et al., 2007). 
 In exploring psychological aspects of smoking among those with schizophrenia, 
researchers have identified smoking as a mechanism to cope with stress.  Smoking offers 
not only a calming effect (anxiety-reducing) and decreased stress, but also a reduction in 
boredom and increased concentration (Esterberg & Compton, 2005).  Finally, those with 
severe mental illness increase the number of cigarettes smoked when experiencing 
increased perceived stress (Dixon et al., 2007; Lasser et al., 2000; Snyder et al., 2008).  
MOTIVATION TO QUIT and MENTAL ILLNESS 
  Those with schizophrenia have impairments in coping and stress management 
skills, with decreased motivation to quit smoking (Esterberg & Compton, 2005).  Some 
study results conclude that individuals with schizophrenia are not motivated to quit 
smoking, nor are they successful in smoking abstinence or cessation (Etter, Mohr, 
Garvin, & Etter, 2004), while some simply lack confidence in their ability to quit 
smoking when compared to the general population (DeLeon, Diaz et al, 2002).  Further, 
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persons with common mental disorders are 30% more likely to increase their cigarette 
smoking from the previous year (Ismail, Sloggett, & DeStavola, 2000). 
  Researchers have also shown that there is a worsening of psychotic symptoms 
with the cessation of smoking (Dalack et al., 1998; Hartman, Leong, Glynn, Wilkins, & 
Jarvik, 1991), and according to Forchuk et al. (2002) most individuals with schizophrenia 
would like to cut down on the number of daily cigarettes smoked or quit altogether.  
While, a study by Glynn and Sussaman (1990) showed that approximately half of those 
with schizophrenia want to stop smoking for health reasons. However, their study 
findings do not support an associated decline in smoking rates for schizophrenics since 
1990, nor do their findings show the same increased smoking cessation trend as the 
general population. 
  When comparing reinforcement values of cigarette smoking among those with 
schizophrenia, depression, and non-psychiatric smokers, both individuals diagnosed with 
schizophrenia and depressed participants chose smoking not only as their preferred 
activity, but also found smoking to be more appealing than alternative rewards (Spring et 
al., 2003).  Recent research purports that smokers in total are becoming significantly 
more nicotine dependent, since smokers who could easily quit have already done so, 
leaving those who are more severely nicotine dependent (Zoler, 2009). 
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CHAPTER III 
HYPOTHESIS DEVELOPMENT 
 Generally, those with schizophrenia display high degrees of nervousness, stress, 
and an inability to deal with challenges posed by life.  The inability to rationally deal 
with difficulties and stressful situations in any coherent and rational fashion, juxtaposed 
with their stressful lives and absence of any social connection in a manner that would 
allow them to utilize available resources for managing stressful situations, contributes to 
further stress and feelings of helplessness, psychosis, or depression.  In such situations, 
frequent and intense smoking may help calm nerves.  Hence, it can be concluded that 
these three aspects of nervousness, stress, and the inability to deal with life’s challenges 
will lead to increased perceived stress.  As smoking is viewed as a stress reliever, those 
with schizophrenia, bipolar or depressive disorders will smoke more to reduce stress. 
 Given that stress is associated with smoking among those with schizophrenia, it is 
important to explore finer grained arguments that relate various dimensions of perceived 
stress to cigarette dependence.  The perceived stress construct focuses upon the level of 
control these individuals feel over the direction of their life events, the measurement of 
their nervousness, stress, and the inability to cope with a variety of life changes and how 
they respond to stressful situations (Esterberg & Compton, 2005).  Contradictory studies 
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have shown there is not much difference in the smoking rates and nicotine dependence 
between those diagnosed with schizophrenia and those diagnosed with other severe 
mental illnesses (deLeon & Diaz, 2005; Kotov et al., 2008). 
Hypothesis 1:   Levels of perceived stress will be significantly greater in the 
group diagnosed with mental illnesses compared with the group drawn from the 
general population 
PERCEIVED STRESS and CIGARETTE DEPENDENCE 
 Schizophrenia is a complex interaction between the biological and genetic factors 
and maladaptive psychosocial deficits, increasing their stress vulnerability and 
diminished ability to cope with daily stressors (Jansen, Gispen-de Wied, & Kahn, 2000).  
This perceived or subjective interpretation of the environment stressors can increase an 
individual’s liability for the onset of psychotic symptoms and variation in intensity of 
symptoms (Nuechterlein & Dawson, 1986; Nuechterlein et al, 1992).  Researchers have 
suggested that nicotine appears to relieve the symptoms of anxiety and decrease the 
apathy and poor concentration that are symptomatic of schizophrenia, with additional 
nicotine properties demonstrating antidepressant effects (Diaz et al., 2009).  
 In studies attempting to explain the stress vulnerability factors, multiple 
researchers have reported an association between psychosocial stress and symptom 
exacerbation in schizophrenia (Duncan et al., 1999; Gispen-de Weid, 2000; Rudnick, 
2001).  However, these findings do not seem to clearly explore what other factors may be 
contributing to an incidence of higher smoking among those diagnosed with 
schizophrenia. 
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Hypothesis 2a: Perceived stress will be positively related to cigarette 
dependence.   
Hypothesis 2b: This relationship will be stronger in those diagnosed with 
schizophrenia. 
PERCEIVED STRESS, CIGARETTE DEPENDENCE and SCHIZOPHRENIA 
A valid argument would be that those with schizophrenia generally attribute most 
life events to be outside their control.  Prior research has suggested that these individuals 
are smoking to self-medicate and regulate their own behavior, with the positive 
symptoms; auditory and visual hallucinations and paranoia directly related to distress 
(Rudnick, 2001). Given this perception of lack of control over important things in life, 
those with schizophrenia would respond by perceiving greater stress and consequently 
resorting to frequent and intense smoking in attempts to alleviate perceived stress, and 
with a higher dependence on cigarettes than smokers with a bipolar disorder.  Although 
the rates of anxiety in bipolar and depression tend to exceed the general population 
(Boylan, Bieling, & Marriott, 2004; Keller, 2006; Kessler, 1999), these individuals 
usually do not experience the extent and severity, or the intensity and duration of 
hallucinations and/or paranoia common to those diagnosed with schizophrenia.  
Hypothesis 3: The relationship between perceived stress and cigarette 
dependence will be stronger among those diagnosed with schizophrenia than in 
those diagnosed with bipolar disorder.  
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 Similar to bipolar, those with depressive disorders are unlikely to experience the 
extent or types of symptoms and forms of hallucinations and delusional thinking 
associated with schizophrenia, symptoms which are likely to exacerbate any feeling of 
perceived stress.  The presence of anxiety acts as a mediator between smoking and 
depression, otherwise there is little evidence of an association linking depressive 
symptoms and smoking (Mykletun, Overland, Aarǿ, Liabǿ, & Stewart, 2008).  Though, 
one study reports that not only do major life events contribute to perceived stress, but day 
to day stressors have an impact on depression levels (Farabaugh et al., 2004).  
Hypothesis 4: The relationship between perceived stress and cigarette 
dependence will be stronger among those diagnosed with schizophrenia than in 
those diagnosed with a depressive disorder. 
MOTIVATION TO QUIT SMOKING 
 Existing research exploring the high incidence of smoking among those with 
schizophrenia has pointed towards the notion that psychiatric patients undergo 
considerable stress and therefore should not be encouraged to give up smoking as a 
pleasurable habit, even though it is a destructive behavior (Dalack & Glassman, 1992).  
Several studies have concluded that smoking cessation programs often fail and 
prevention strategies are seldom achieved due to poor motivation in those with 
schizophrenia (Forchuk, Norman, Malla, Vos, & Martin, 1997; Forchuk et al, 2002).  
This is in contrast to smokers in the general population who are more likely to be 
successful with smoking cessation efforts, but they have an added advantage because 
they are less likely to experience adverse withdrawal symptoms affecting their mental 
status (Mykletun et al., 2008).  A recent study by Diaz et al. (2009), reports the diagnosis 
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of schizophrenia is associated with a decreased ability to sustain smoking abstinence, 
though it is unknown if this difference is also similar in those with other diagnosable 
mental disorders. 
Hypothesis 5a: Perceived Stress will be negatively related to motivation to quit 
smoking.   
Hypothesis 5b: This relationship will be stronger in those diagnosed with a 
mental illness. 
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CHAPTER IV 
METHODS 
RESEARCH SETTINGS and DESIGN 
 This sample size selection was based on the accessibility of participants from two 
institutions located in the Cleveland, Ohio area, with the number of participants 
proportionate to the general population size of each facility.  I selected the sample based 
upon an attempt to collect maximum variance in the dependent variable, cigarette 
dependence.  This strategy is recommended when randomization of the sample is not 
possible.  This cross-sectional study compared current smokers and non-smokers from an 
inpatient mental health facility in Willoughby, Ohio and students and faculty who 
reported themselves as current smokers and non-smokers from Cleveland State 
University, Cleveland, Ohio.  Questionnaires for this survey-based research were used to 
ensure that responses would be anonymous for this non-randomized sample consisting of 
participants voluntarily hospitalized with a mental illness, and Cleveland State University 
students and faculty between the ages of 18-81.  The data analysis consisted of t-tests and 
partial correlations. 
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DATA COLLECTION 
 Prior to initiating this research, the informed consent for both the hospitalized 
individuals and the Cleveland State University participants was approved by Cleveland 
State University’s Institutional Review Board, and approval to include hospitalized 
patients was obtained from the Medical Executive Committee at Windsor-Laurelwood 
Center for Behavioral Medicine.  Initiation began in November 2008 and continued until 
March 2009.  All participants signed the informed consent form prior to participation and 
completing the survey questionnaires.  All questionnaires collected contain only 
numerical identification; names identifying participants were not obtained on the survey 
questionnaires in order to protect the anonymity of participants.  All participants were 
allowed to withdraw at any time; although, to date no participant has withdrawn consent 
after completing the study questionnaires. 
SAMPLE 
The study sample consisted of a total of 343 participants; of which 168 were 
diagnosed with a mental illness and 175 were not diagnosed with a mental illness. In 
terms of age groups, 48.5% of the sample were individuals between the ages of 18-27 
years of age, 17.2% of the sample were between the ages of 28-37, 17.1% were at ages 
between 38-47 years, 12.4% were between the ages of 48-57, 3.3% were 58-69 years of 
age, those at ages 70-81 were 1.5% of the total sample.    
Of the total sample 51% were not diagnosed with any mental illness.  49% were 
diagnosed with a mental illness.  The mentally ill included 9.9% diagnosed with 
schizophrenia, 15.2% diagnosed with bipolar disorder, 19.2% diagnosed with depressive 
disorder, and 4.7% with a non-specified mental illness.  Forty-two % of the sample were 
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hospitalized patients (data collected at Windsor Laurelwood Center for Behavioral 
Medicine), while 58% of the total sample were non-hospitalized individuals (data 
collected at Cleveland State University).  
Of the smokers in the sample for this study, 21.6% started smoking during their 
pre-adolescent years between 6-13 years of age.  Most of the smokers in our sample, 
58.8% started smoking during their adolescent years between the ages of 14-18 years.  
For those who started smoking as adults, 17.5% were between the ages of 19-30 years, 
and the remaining 2.1% started between the ages of 33-40 years. 
Consistent with prior research and published government data on smoking rates 
for those with a diagnosed mental illness, this sampling of participants reported similar 
smoking rates.  88% of those with schizophrenia currently smoke, 75% of those 
diagnosed with bipolar disorder smoke, 74% of those with depressive disorders smoke, 
and 43% diagnosed with “other” mental illnesses, i.e., attention deficit hyperactivity 
disorder, generalized anxiety disorder, and post traumatic shock disorder, are smokers.  
This evidence shows that the sample for this study is fairly representative of those with 
mental illnesses. 
CONFOUNDING VARIABLES 
 Demographic information was collected reflecting the smoker’s age, gender, 
number of years smoked, and age first started smoking.  In conducting analyses, I 
controlled for variance associated with these variables, since each demographic variable 
could potentially influence the relationship between the independent variable and the 
dependent variable.   
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SCALES 
In order to collect data for the independent variable, stress, the Perceived Stress 
Scale was completed by all participants, both smokers and non-smokers alike.  The 
information needed to determine reported smokers cigarette dependence, the dependent 
variable, was provided by utilizing the Cigarette Dependence Scale.  All smokers 
completed the Reasons for Quitting Scale to determine motivational factors for smoking 
cessation. 
Perceived Stress Scale 
 To capture levels of perceived stress, this research project collected data utilizing 
the 10 item self-report questionnaire, the Perceived Stress Scale (Cohen et al, 1983; 
Appendix A), which was completed by all participants.  This self-rating scale was 
developed primarily as a research instrument to demonstrate the consequences of stress 
on disease processes.  This scale emphasizes the importance of the subjective 
interpretation of life events and the degree to which respondents perceive their life 
situations to be stressful, unpredictable, uncontrollable and overloading.  The test-retest 
reliability indices for this scale range from 0.84 to 0.86. (American Psychiatric, 2000b, p. 
232-235). 
Cigarette Dependence Scale 
 In order to measure the dependent variable, an adaptation of the Cigarette 
Dependence Scale was administered to all individuals reporting themselves as smokers 
(Appendix B).  Due to a low correlation one item was dropped from the composition of 
the scale.  The original Cigarette Dependence Scale was designed to provide an ordinal 
measure of nicotine dependence related to cigarette smoking, consisting of a 5 item self-
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reporting questionnaire evaluating the quantity of cigarette consumption, the compulsion 
to use, and dependence.  This scale is useful as a screen for nicotine dependence and as a 
severity rating that can be used for treatment planning and prognostic judgments.  Test-
retest reliability (r>0.83) & internal consistency (Cronbach's α > 0.84). (Etter, Houezec, 
& Perneger, 2003). 
Reasons for Quitting Scale 
 The Reasons for Quitting Scale (Appendix C) was completed by all smokers.  
This scale was developed for smokers who were interested in receiving minimal self-help 
interventions for smoking cessation.  This scale applies an intrinsic-extrinsic model of 
motivation for smoking cessation.  It contains 10 intrinsic items related to health concerns 
and self-control and 10 extrinsic items that related to social pressure and immediate 
reinforcement.  Earlier reported alpha reliability coefficients for the overall intrinsic and 
extrinsic scales were 0.83 and 0.75, respectively (Curry, Grothaus, & McBride, 1997).  
VALIDITY OF SCALES 
 Since these scales have been used in previous published studies, the validity is 
commonly accepted (Hewitt, Flett, & Mosher, 1992; Marshall et al., 2009; Stavem, 
Røgeberg, Olsen, & Boe, 2008).  However, as part of this research a factor analysis was 
done with each scale to determine convergent validity of the constructs in this study.  
Divergent validity was not a concern since the scales have been utilized in many 
published studies (Addington, el-Guebaly, Campbell, Hodgins, Addington, 1998, Etter, 
2008; Naquin & Gilbert, 1996).  
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CHAPTER V 
RESULTS 
The first hypothesis of this study was tested using an independent samples t-test 
(Table 1a & 1b).  The mean level of perceived stress for those diagnosed with a mental 
illness was 2.44 while the mean level of perceived stress in the general population part of 
the sample was 1.84.  The difference of 0.60 was statistically significant (t=7.74 at p= 
0.000).  This test provides support for hypothesis 1.  
 
Table 1a                                        Group Statistics 
 
Diagnosis N Mean 
Std. 
Deviation Std. Error Mean 
Perceived Stress Mentally Ill 167 2.4365 .74149 .05738 
General Population 174 1.8351 .69280 .05252 
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Table 1b                                        Independent Samples Test 
  
Levene's 
Test for 
Equality of 
Variances t-test for Equality of Means 
  
F Sig. t df 
Sig. 
2-
tailed 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
  
Lower Upper 
Perceived Stress Equal 
variances 
assumed 
.535 .465 7.743 339 .000 .60147 .07768 .44868 .75426 
Equal 
variances 
not assumed 
  
7.732 335.028 .000 .60147 .07779 .44846 .75448 
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The second hypothesis consisted of two parts (Table 2a & 2b).  First, I tested the 
strength of the relationship between perceived stress and levels of cigarette dependence.  
I used a partial correlation between these two variables, controlling for age, gender, years 
of smoking, and age at which the research participants first started smoking.  The partial 
correlation was statistically significant (partial r=0.245, p=0.001).  This provides support 
for hypothesis 2a.  In testing hypothesis 2b, I examined the same relationship between 
perceived stress and cigarette dependence for the group of schizophrenics in this sample.  
This partial correlation was weaker than the overall sample and statistically insignificant 
(partial r=0.037, p=0.857), hence hypothesis 2b was not supported.  
 
Table 2a                                        Correlations 
Control Variables 
Perceived 
Stress 
Cigarette 
Dependence 
Age  
Gender  
Number years smoked 
Age first started smoking 
Perceived Stress Correlation 1.000 .245 
Significance 
(2-tailed) 
. aa.001 
df 0 179 
Cigarette 
Dependence 
Correlation .245 1.000 
Significance 
(2-tailed) 
.001 . 
df 179 0 
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Table 2b                                         Correlations 
Control Variables 
Perceived 
Stress 
Cigarette 
Dependence 
Age 
Gender 
Number of years smoked 
Age first started smoking 
Perceived Stress Correlation 1.000 .037 
Significance 
(2-tailed) 
. .857 
df 0 24 
Cigarette 
Dependence 
Correlation .037 1.000 
Significance 
(2-tailed) 
.857 . 
df 24 0 
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The third hypothesis (Table 3) posited a stronger relationship between perceived 
stress and cigarette dependence among schizophrenics than among those diagnosed with 
bipolar disorder.  The partial correlation for this relationship among schizophrenics, as 
reported in results for hypothesis 2b was 0.037.  Controlling for the same variables, this 
relationship among those diagnosed with bipolar disorder was a partial correlation of 
0.015 (p=0.930).  Although this relationship is somewhat stronger among schizophrenics 
(difference=0.022), both partial correlations are statistically insignificant and therefore 
hypothesis 3 was not supported. 
 
 
 
Table 3                                                     Correlations 
Control Variables 
Perceived 
Stress 
Cigarette 
Dependence 
 
Perceived Stress Correlation 1.000 .015 
Significance (2-
tailed) 
. .930 
df 0 33 
Cigarette 
Dependence 
Correlation .015 1.000 
Significance (2-
tailed) 
.930 . 
df 33 0 
 29 
The fourth hypothesis (Table 4) examined the partial correlation difference 
between perceived stress and cigarette dependence between those diagnosed with 
schizophrenia (partial r=0.037) and those diagnosed with depressive disorder (partial 
r=0.120, p=0.436).  Both these partial correlations were statistically insignificant and 
hence hypothesis 4 in this study was not supported. 
 
 
 
 
 
 
 
 
 
 
     Table 4                                         Correlations 
Control Variables 
Perceived 
Stress 
Cigarette 
Dependence 
Age  
Gender 
Number years 
smoked 
Age first started 
smoking 
Perceived Stress Correlation 1.000 .120 
Significance (2-
tailed) 
. .436 
df 0 42 
Cigarette 
Dependence 
Correlation .120 1.000 
Significance (2-
tailed) 
.436 . 
df 42 0 
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The fifth and final hypothesis of this study argued that perceived stress is first, 
negatively related to motivation to quit (Table 5a & 5b).  Controlling for age, gender, 
years of smoking, and age at which the research participant first started smoking, this 
partial correlation was low and statistically insignificant (partial r=0.091, p=0.225).  
Hence, hypothesis 5a was not supported.  To test hypothesis 5b, I computed the partial 
correlation between perceived stress and motivation to quit among those diagnosed with a 
mental illness (partial r=0.076, p=0.413).  Given that this partial correlation was not 
greater than the overall sample and that both partial correlations were statistically 
insignificant, I concluded that hypothesis 5b was also not supported.   
 
 
 
 
 
 
 
 
 
 
 
Table 5a                                       Correlations 
Control Variables 
Perceived 
Stress 
Motivation to 
Quit 
Age  
Gender 
Number years smoked 
Age first started smoking 
Perceived Stress Correlation 1.000 .091 
Significance 
(2-tailed) 
. .225 
df 0 178 
Motivation to Quit Correlation .091 1.000 
Significance 
(2-tailed) 
.225 . 
df 178 0 
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Table 5b                                       Correlations 
Control Variables 
Perceived 
Stress 
Motivation to 
Quit 
Age 
Gender 
Number of years smoked 
Age first started smoking 
Perceived Stress Correlation 1.000 .076 
Significance 
(2-tailed) 
. .413 
df 0 117 
Motivation to Quit Correlation .076 1.000 
Significance 
(2-tailed) 
.413 . 
df 117 0 
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LIMITATIONS 
There are several limitations inherent in this study.  Firstly, this sample is non-
randomizing sampling of those with mental illnesses and a somewhat unlikely 
representation of the general population of severe mental illnesses.  One of the main 
limitations of this study using these self-reporting questionnaires as survey instruments is 
that the self-report cannot be verified by other sources.  Neither screening procedures nor 
chart reviews were performed to accurately verify the psychiatric disorder as specified by 
the participants.  Psychiatric diagnoses are categorized according to the Diagnostic and 
Statistical Manual of Mental Disorders, 4th. Edition (DSM-IV), published by the 
American Psychiatric Association for the purpose of classifying psychiatric diagnoses in 
the United States (American Psychiatric Association [AMA], 2000a), though, there is no 
reason to suspect the patients or the students purposefully misreported information.  
Secondly, I failed to collect data on any current psychotropic medications; antipsychotics 
or antidepressants which could influence the perceived stress levels as reported by the 
participants.  Thirdly, the hospital environment is another factor which has a probability 
of influencing both the responses for perceived stress and cigarette dependence.  The 
strict smoking restrictions established on each hospital units are likely to cause some 
distress or anxiety, with smoke breaks offered every 2 hours versus the liberal smoking 
opportunities for individuals when not hospitalized.  Lastly, I did not capture socio-
demographic information pertinent to race, ethnicity, educational level, socio-economic 
status, marital status, and any additional co-morbid illnesses or possible confounding 
factors such as alcohol or drug use and abuse.  
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CHAPTER VI 
CONCLUSION 
  The main objective of this study was to examine if perceived stress levels are 
greater in those diagnosed with the mental illnesses of schizophrenia, bipolar, and 
depressive disorders.  The second aim was to determine if perceived stress influences 
cigarette dependence in individuals diagnosed with these distinctly different mental 
illnesses.  Another aim was to determine if perceived stress influences motivation to quit 
smoking for those with schizophrenia, bipolar, or depressive disorders.  In a 
comprehensive model showing a relationship between perceived stress and smoking for 
those diagnosed with schizophrenia, many independent variables should be included.  
According to the American Psychiatric Association classification of schizophrenia, 
several types are categorized and recognized by the predominant symptomatology; with 
the dominant types characterized as paranoid, disorganized, catatonic, schizophreniform, 
and schizoaffective, and additional sub-types of the dominant characteristic (APA, 
2000a).  This disorder spectrum makes it more inherently difficult to make a 
generalization for all types and sub-types when looking at how specific factors influence 
both their perceived stress and smoking habits.  Therefore, symptomatology may be a key 
variable impacting the stress and smoking relationship.   
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Though, as a group with similar characteristics, those with schizophrenia lack the 
social support systems more prevalent and available to those with bipolar and depressive 
disorders, thus the presence or relative absence of these support systems can be an 
independent variable.  Based on the schizophrenics presenting symptoms of social apathy 
and withdrawal, it can be theorized that it is more difficult to engage those with these 
symptoms, and a general stigmatism of schizophrenia makes it more difficult to include 
and involve families and communities, increasing their perceived stress.  Those with 
schizophrenia are more likely to be unemployed due to the severity of their illness; 
therefore the lack of this type of socialization and lack of financial support contributes to 
their perceived stress.  Compared to schizophrenia, those with bipolar and depressive 
disorders are more easily integrated into the social framework of work, families, and 
communities, and they face less stigmatism of “being crazy”.  Thus, social acceptance 
may be a key variable impacting the stress and smoking relationship.  Also, those with 
bipolar and depressive disorders are more cognizant of medication adherence and 
recovery than those with schizophrenia, hence, making them more socially acceptable 
since they are less likely to display bizarre behaviors.  Adherence to medication is also a 
possible independent variable.  
Without any significant difference of perceived stress and cigarette dependence 
among all three mental illness groups, it is possible that the lack of a significant 
relationship hinges on the impaired awareness of the schizophrenics.  This concept aligns 
with research by Cooke et al. (2007) in that those with greater awareness of their illness 
experience more stress.  In my study, the individuals with schizophrenia have been 
hospitalized due to worsening or escalation of their psychotic symptoms, and 
decompensation usually presented with disturbances in thought or cognition and a loss of 
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reality of self and relationship to the external world.  Thus, they experience lesser degrees 
of awareness of their illness and the severity of their symptoms, being instead focused on 
internal stimuli.  Hence, it can be concluded that they are less likely to report equivalent 
or similar stress levels when not hospitalized. Thus hospitalization may be a key variable 
impacting these relationships. 
Schizophrenia is an illness with cognitive deficits, flight of ideas, thought 
disorganization, hallucinations, paranoia, and bizarre “delusions that express a loss of 
control over mind or body” (APA, 2000a).  A recent study noted  not only do those with 
schizophrenia feel a loss of identity, viewing their mental illness as a personal 
punishment, but also do not see themselves working towards recovery when asked to 
describe their illness beliefs (Kinderman, Setzu, Lobban, & Salmon, 2006).   This 
coalesce of losses can easily influence their perceived stress and smoking habits.   
The results of this research study support previous research findings that levels of 
perceived stress are greater in those with schizophrenia, bipolar, and depressive disorders 
in comparison to the general public.  However, I did not find support for a stronger 
relationship between perceived stress and cigarette dependence among those diagnosed 
with schizophrenia compared with other mental illnesses.  There could be many reasons 
that the relationship in schizophrenics in this study was not as robust as expected.  First, 
there is a possibility that the convenience sample collected as part of this research did not 
include these differences.  Secondly, there has not been much work examining 
differential stress and smoking relationships between different mental disorders.  Most 
stress and smoking research, as shown in the literature review, has focused on the 
commonly observed dominant relationship between stress and smoking among 
schizophrenics.  Third, the instruments used to measure potential differences of perceived 
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stress and cigarette dependence among the classes of mental illness may not have been 
sensitive enough to discern any subtle variations that were present. 
 One unexpected result of this research study shows that perceived stress does not 
have a negative correlation with motivation to quit smoking.  Instead, this data shows that 
there is no relationship between stress and motivation to quit, which is in conflict with 
research by Dalack and Glassman (1992) who recommended that those with mental 
illness should not be encouraged to quit smoking when factoring in their stress levels.  
Conversely, this study lends more than tentative support for the notion that smoking 
cessation initiatives can be considered and implemented for those with mental illnesses. 
 This research study has shown that those with mental illnesses experience greater 
perceived stress than the general population, with findings that the smoking rates for 
those with mental illnesses are comparable to published reports by the CDC.  This has 
become a health care crisis which cannot be ignored, and it is irresponsible of the health 
care community not to intervene and offer smoking cessation information and programs 
to psychiatric patients.  The same promising treatments for nicotine addiction available to 
the general public can be modified to accommodate those with mental illnesses.   
However, few smoking cessation programs have been targeted or tailored to the needs of 
psychiatric patients, particularly those with schizophrenia (George, Vessicchio, Termine, 
Bregartner et al., 2002; Rohsenow, n.d.).  A collaborative approach is needed to assess 
needs, available resources, establish guidelines and interventions in order to provide the 
greatest opportunity for those with mental illnesses who smoke.   
 Future research investigating whether treatment tailored specifically to the 
psychiatric smoker represents a more effective approach to long-term abstinence is 
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necessary.  This research can be designed as comparative assessments of the relative 
efficacy of interventions that provide information, build confidence, and teach practical 
strategies.  Further, it is essential that smoking cessation programs for those with mental 
illnesses include support staff and resources for motivation building, teaching coping 
skills and techniques; while allowing for long-term quit plans (Meadows et al, 2001), and 
the effectiveness of these approaches can be evaluated through survey based research.  
Success should be achievable if modeled and built on smoking cessation interventions 
and outcomes designed for the general public, with some modification to include 
motivation and coping strategies specifically designed for psychiatric smokers.  Future 
research must also investigate availably of resources and staff at psychiatric facilities, 
who are in a strong position to implement motivational and coping programs during 
periods of hospitalization. The window of opportunity provided by hospitalization should 
be used to initiate smoking cessation interventions and treatments focused on this 
particular group of smokers who have the greatest propensity for smoking.  
 The research initiated in this study can be extended in several ways.  Obviously, 
cigarette dependence has many antecedents.  It would be very useful to identify, classify, 
conceptualize and test these antecedents and their relationships with cigarette 
dependence.  For instance, individual level attributes such as socio-economic background 
and lifestyle choices could be important antecedents to levels of smoking that might shed 
more light on the relationship between perceived stress and smoking.  Another avenue of 
research could be to identify individual-level moderators and mediators that influence the 
nature and magnitude of the relationship between stress and smoking.  For example, 
symptomatology and hospitalization can be conceptualized as moderators in the 
relationship between perceived stress and cigarette dependence.  Furthermore, collecting 
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samples from many locations, especially with randomization may allow for greater 
generalization of results.   
 This research has initiated a broader look at the somewhat assumed and tacit 
knowledge underpinning differences in stress levels and smoking rates among individuals 
diagnosed with different mental disorders.  Future research is needed to help clarify the 
interactive effects of stress, smoking, and psychiatric disorders in order to understand 
what effective treatment approaches to smoking cessation will most benefit this 
population.  There are tremendous quality-of-life and cost benefits for developing a 
deeper understanding of these relationships, therefore further research along these 
streams is merited and long overdue.   
 This research has offered some insight into significant interactive effects between 
stress, smoking, and psychiatric disorders, which pose particular challenges to smoking 
cessation that must be addressed.  This research study should also heighten interest in 
outcomes of smoking cessation strategies for persons with mental illnesses.  I hope to 
pursue this avenue of research with intervention and outcome studies, possibly looking at 
the effectiveness of smoking cessation programs with concurrent nicotine replacement 
and behavioral techniques, or consider specially targeted educational efforts to reduce 
their smoking rates.  Because effective smoking cessation treatments are available, every 
patient with a psychiatric illness who uses tobacco should be offered at least some form 
of cessation treatment.  
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Appendix A 
Perceived Stress Scale 
 
Instructions: The questions in this scale ask you about your feelings and thoughts during the last month. In each case, please indicate 
with a check how often you felt or thought a certain way. 
 
1. In the last month, how often have you been upset because of something that happened unexpectedly? 
____0=never ____l =almost never ____2=sometimes ____3=fairly often ___4=very often 
2. In the last month, how often have you felt that you were unable to control the important things in your life? 
____ 0=never ___1 =almost never ____2=sometimes ____3=fairly often ____4=very often 
3. In the last month, how often have you felt nervous and “stressed”? 
 ____0=never ___1 =almost never ____2=sometimes ____3=fairly often ____4=very often 
4. In the last month, how often have you felt confident about your ability to handle your personal problems? 
____0=never____1=almost never ____2=sometimes ____3=fairly often ____4= very often 
5. In the last month, how often have you felt that things were going your way? 
____0=never ____1=almost never ____2=sometimes ____3=fairly often ____4= very often 
6. In the last month, how often have you found that you could not cope with all the things that you had to do? 
____0=never ____1 =almost never ____2=sometimes ____3=fairly often ____4=very often 
7. In the last month, how often have you been able to control irritations in your life? 
____0=never ____ l=almost never ____2=sometimes ____3=fairly often ____ 4=very often  
8. In the last month, how often have you felt that you were on top of things? 
____0=never ____l=almost never ____2=sometimes ____3=fairly often ____4=very often 
9. In the last month, how often have you been angered because of things that were outside of your control?  
____0=never ____1=almost never ____2=sometimes ____3=fairly often ____4=very often 
10. In the last month, how often have you felt difficulties were piling up so high that you could not overcome them? 
____0=never ____l=almost never _____2=sometimes ____3=fairly often ____4=very often 
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                                                           Appendix B 
                                                 Cigarette Dependence Scale 
1. Please circle the average number of cigarettes you smoke per day? 
 
A.      0-5 
B.      6-10 
C.     11-20 
D.     21-29 
E.     30+ 
2.      Usually, how soon after waking up do you smoke your first cigarette (in minutes)? 
 
A.     0-5 
B.     6-15 
C.     16-30 
D.     31-60 
E.     61+ 
  3.      For you, quitting smoking for good would be: 
A.      Impossible 
B.    Very Difficult 
C.      Fairly Difficult 
D.      Fairly Easy 
E.      Very Easy 
4.     After a few hours without smoking, I feel an irresistible urge to smoke 
A.     Totally disagree 
B.    Somewhat disagree 
 
   C.     Neither agree nor disagree 
 
 D.    Somewhat agree 
 
E.    Fully agree 
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Appendix C  
Reasons for Quitting Scale 
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